Work

Mitochondrial dysfunction–ferroptosis crosstalk drives bone remodeling imbalance in osteoporosis: mechanisms and recent advances

Year: 2026
Type: article
Abstract: Osteoporosis is a highly prevalent metabolic bone disease worldwide, and its central pathological mechanism is an imbalance in bone remodeling. Mitochondrial dysfunction and ferroptosis, two key mechanisms of cellular injury, have recently been shown to jointly drive the onset and progression of osteoporosis through complex crosstalk networks. Mitochondrial dysfunction is characterized by abnormal mitochondrial dynamics, impaired oxidative phosphorylation, and defective mitophagy, whereas ferroptosis is defined by iron overload, lipid peroxidation, and glutathione peroxidase 4 (GPX4) inactivation. These processes interact in osteoblasts, osteoclasts, and osteocytes. Reactive oxygen species (ROS) signaling, iron metabolic disorder, and the mitochondria–endoplasmic reticulum stress axis play central roles in bone remodeling imbalance by coordinately regulating cell fate and bone metabolic homeostasis. This narrative review provides a structured synthesis of recent advances in the crosstalk between mitochondrial dysfunction and ferroptosis, integrating evidence from molecular biology, cell biology, animal models, and selected clinical observations. The aim is to provide a theoretical basis and identify potential intervention targets for the development of targeted therapies for osteoporosis.
Language: English
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W7234413810
FWCI:
Cites: 150
Cited by:
Related to: 10